- High binding capacity for polyclonal and monoclonal antibodies
- No non-specific binding—patented ICEtech™ (Inert Coating Enhancement Technology, U.S. Patent No.6,802,966) completely passivates the silica surface to ensure highly purified antibodies
- Long lifetime—proven over 300 runs
- Standard HPLC column format uses biocompatible PEEK hardware for use with HPLC or FPLC instruments
The Venture® A column is the first affinity column to take advantage of silica’s rigid porous structure, providing increased productivity over other supports. Grace’s patented technology, ICEtech™ (inert coating enhancement technology), eliminates non-specific binding on the silica surface enabling the breakthrough use of silica for affinity separations.
Venture® A columns use a recombinant protein A ligand for binding antibodies. They are designed to perform both as an analytical tool for fast, accurate measurement of antibody titers and as a quick and easy way to purify antibodies from cell culture supernate, serum, or other feedstocks.
|
